With Exosome Analysis, Highly Sensitive Monitoring of ESR1 Mutations Is Possible
With the rise of precision oncology therapies — particularly those that target specific variants or remain effective despite specific mutations — there is more need than ever for routine, highly sensitive monitoring of the cancer mutations that arise during the course of a patient’s treatment journey.